← Leaderboards
Srinivas R Sadda
Doheny Eye Institute
$2,836,779
Attributed
$6,165,805
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,165,805 · 6
By mechanism
R01$4,252,872 · 3
R21$1,912,933 · 3
Top collaborators
- Jonathan L. Haines4 shared
- Zhihong Hu4 shared
- Margaret A Pericak-Vance4 shared
- Dwight E Stambolian4 shared
- Scott E Fraser2 shared
- Kang Zhang2 shared
- Yuhua Liang Zhang2 shared
Most similar at Doheny Eye Institute
Same institution · by research overlap
- Margaret A Pericak-Vance$129,262,654
- Jonathan L. Haines$49,178,955
- Zhihong Hu$428,806
Others in their field
Top investigators on “Blindness”
- Randall J Bateman · Washington University$137,189,188
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$96,562,493
Research focus
BlindnessImagePhenotypeRetinaHigh RiskRisk FactorsClinical TrialsAge Related Macular DegenerationColorClinical ResearchFundusClinicVisitClinical PracticeOptical Coherence TomographyMaculaStagingAtrophicDeep LearningBaseResearch PersonnelTherapeutic TrialsRetinal DiseasesElderly
Grant awards (16)
Epidemiology of Biomarkers of AMD Progression$588,379
R01 · FY2025 · EY · contact PI
In vivo Imaging of the Human Retina at the Molecular Level$514,294
R01 · FY2025 · EY · contact PI
Epidemiology of Biomarkers of AMD Progression$585,469
R01 · FY2024 · EY · contact PI
In vivo Imaging of the Human Retina at the Molecular Level$532,924
R01 · FY2024 · EY · contact PI
Epidemiology of Biomarkers of AMD Progression$582,584
R01 · FY2023 · EY · contact PI
Epidemiology of Biomarkers of AMD Progression$640,560
R01 · FY2021 · EY · contact PI
Artificial Intelligence for Assessment of Stargardt Macular Atrophy$190,362
R21 · FY2021 · EY
Artificial Intelligence for Assessment of Stargardt Macular Atrophy$235,500
R21 · FY2020 · EY
Discovery and Validation of AMD Biomarkers for Progression Using Deep Learning$196,250
R21 · FY2020 · EY
Discovery and Validation of AMD Biomarkers for Progression Using Deep Learning$235,500
R21 · FY2019 · EY
Genetic Susceptibility for Development of Proliferative Diabetic Retinopathy$396,581
R01 · FY2010 · EY · contact PI
Genetic Susceptibility for Development of Proliferative Diabetic Retinopathy$412,081
R01 · FY2009 · EY · contact PI
Objective Diagnosis & Quantification of Retinal Disease$342,030
R21 · FY2007 · EY · contact PI
Objective Diagnosis & Quantification of Retinal Disease$352,681
R21 · FY2006 · EY · contact PI
Objective Diagnosis &Quantification of Retinal Disease$172,840
R21 · FY2005 · EY
Objective Diagnosis &Quantification of Retinal Disease$187,770
R21 · FY2004 · EY